Based on our data, we suggest that conservation management might be suitable for patients at low or intermediate risk associated with tumor involvement ≤5% in TURP specimens, PSA_TURP ≤ 4 ng/mL, and ≥68% PSA reduction following TURP. Here, KLK3 is linked to neoplasm.